The lawyer behind a lawsuit brought against LSV Asset Management hopes a victory in court will benefit not only the plaintiffs but employees of other firms facing similar situations. A challenge from ...

Perplexity unveiled Computer for Counsel on June 24 — a legal-specific configuration of its agentic platform that routes tasks across more than 20 frontier AI models while connecting to the document ...

A federal judge allowed most of a whistleblower lawsuit against Harvard to proceed Tuesday, letting two claims advance in a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, ...

Washington — The final weeks of the Supreme Court's term are fast approaching, and the justices are poised to hand down decisions in some of its most significant cases before they go their separate ...

The Supreme Court handed down 58 opinions in all, adjourning a momentous term in which the justices have confronted cases dealing with President Donald Trump’s power, voting rights and transgender ...

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

Rare-disease specialist Catalyst Pharmaceuticals is set to be acquired by healthcare group Angelini Pharma in a $4.1 billion deal. Angelini will pay $31.50 for each of Nasdaq-listed Catalyst’s ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. The Italian company Angelini Pharma ...